| Product Code: ETC8458849 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Myanmar Patented Drugs Market Overview |
3.1 Myanmar Country Macro Economic Indicators |
3.2 Myanmar Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Myanmar Patented Drugs Market - Industry Life Cycle |
3.4 Myanmar Patented Drugs Market - Porter's Five Forces |
3.5 Myanmar Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Myanmar Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Myanmar Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Myanmar Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing healthcare expenditure in Myanmar |
4.2.2 Growing awareness about patented drugs and their benefits |
4.2.3 Favorable government policies and regulations supporting the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 High cost of patented drugs compared to generic alternatives |
4.3.3 Lack of healthcare infrastructure and skilled professionals |
5 Myanmar Patented Drugs Market Trends |
6 Myanmar Patented Drugs Market, By Types |
6.1 Myanmar Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Myanmar Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Myanmar Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Myanmar Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Myanmar Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Myanmar Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Myanmar Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Myanmar Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Myanmar Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Myanmar Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Myanmar Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Myanmar Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Myanmar Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Myanmar Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Myanmar Patented Drugs Market Import-Export Trade Statistics |
7.1 Myanmar Patented Drugs Market Export to Major Countries |
7.2 Myanmar Patented Drugs Market Imports from Major Countries |
8 Myanmar Patented Drugs Market Key Performance Indicators |
8.1 Number of new patented drugs approved for sale in Myanmar |
8.2 Investment in research and development of patented drugs in the country |
8.3 Percentage of population covered by health insurance that includes coverage for patented drugs |
9 Myanmar Patented Drugs Market - Opportunity Assessment |
9.1 Myanmar Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Myanmar Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Myanmar Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Myanmar Patented Drugs Market - Competitive Landscape |
10.1 Myanmar Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Myanmar Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here